PAPER Cho H, Seo SW, Kim JH, Kim C, Ye BS, Kim GH, Noh Y, Kim HJ, Yoon CW, Seong JK, Kim CH, Kang SJ, Chin J, Kim ST, Lee KH, Na DL
SEARCH RESULTS
330907 RESULTS
PAPER Rohrer JD, Caso F, Mahoney C, Henry M, Rosen HJ, Rabinovici G, Rossor MN, Miller B, Warren JD, Fox NC, Ridgway GR, Gorno-Tempini ML
Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia.
Brain Lang. 2013 Feb 7; PubMed: 23395096PAPER Wang RT, Jin D, Li Y, Liang QC
Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease.
J Psychiatr Res. 2013 May;47(5):644-9. PubMed: 23395109PAPER Potter GG, Wagner HR, Burke JR, Plassman BL, Welsh-Bohmer KA, Steffens DC
Neuropsychological predictors of dementia in late-life major depressive disorder.
Am J Geriatr Psychiatry. 2013 Mar;21(3):297-306. PubMed: 23395197PAPER Tiiman A, Palumaa P, Tõugu V
The missing link in the amyloid cascade of Alzheimer's disease- metal ions.
Neurochem Int. 2013 Mar;62(4):367-78. PubMed: 23395747PAPER Zhang J, Zhen YF, Pu-Bu-Ci-Ren, Song LG, Kong WN, Shao TM, Li X, Chai XQ
Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus.
Behav Brain Res. 2013 May 1;244:70-81. PubMed: 23396166PAPER Dos Santos VV, Santos DB, Lach G, Rodrigues AL, Farina M, De Lima TC, Prediger RD
Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
Behav Brain Res. 2013 May 1;244:107-15. PubMed: 23396168PAPER Paolini S, Paciaroni L, Manca A, Rossi R, Fornarelli D, Cappa SF, Abbatecola AM, Scarpino O
Change of accent as an atypical onset of non fluent primary progressive aphasia.
Behav Neurol. 2013 Feb 8; PubMed: 23396217PAPER Caffarra P, Gardini S, Dieci F, Copelli S, Maset L, Farina E, Grossi E
The qualitative scoring MMSE pentagon test (QSPT): A new method for differentiating dementia with Lewy Body from Alzheimer's disease.
Behav Neurol. 2013 Feb 8; PubMed: 23396218PAPER Piscopo P, Rivabene R, Galimberti D, Crestini A, Talarico G, Vanacore N, Scarpini E, Bruno G, Confaloni A
Gender Effects on Plasma PGRN Levels in Patients with Alzheimer's Disease: A Preliminary Study.
J Alzheimers Dis. 2013 Jan 1;35(2):313-8. PubMed: 23396349PAPER Porzoor A, Macreadie IG
Application of Yeast to Study the Tau and Amyloid-β Abnormalities of Alzheimer's Disease.
J Alzheimers Dis. 2013 Jan 1;35(2):217-25. PubMed: 23396350PAPER Perry G, Zhu X, Smith MA, Sorensen A, Avila J
Preface. Alzheimer's disease: advances for a new century.
J Alzheimers Dis. 2013;33 Suppl 1:S1. PubMed: 23397602PAPER Stillman MJ
What’s next in Alzheimer research? Highlights from the ANA President's Symposium.
Ann Neurol. 2012 Dec;72(6):A7-8. PubMed: 23280852PAPER Meek AR, Simms GA, Weaver DF
Searching for an endogenous anti-Alzheimer molecule: identifying small molecules in the brain that slow Alzheimer disease progression by inhibition of β-amyloid aggregation.
J Psychiatry Neurosci. 2012 Feb 12;38(1):120166. PubMed: 23394811PAPER Rosenberg PB, Wong DF, Edell SL, Ross JS, Joshi AD, Brašić JR, Zhou Y, Raymont V, Kumar A, Ravert HT, Dannals RF, Pontecorvo MJ, Skovronsky DM, Lyketsos CG
Cognition and Amyloid Load in Alzheimer Disease Imaged With Florbetapir F 18(AV-45) Positron Emission Tomography.
Am J Geriatr Psychiatry. 2013 Mar;21(3):272-8. PubMed: 23395194Current Filters
No filters selected